| 18th Nov 2019 4:03 pm |
RNS |
Directorate Change |
| 14th Nov 2019 4:00 pm |
RNS |
Holding(s) in Company |
| 14th Nov 2019 7:00 am |
RNS |
Updated loan facility agreement with MidCap |
| 13th Nov 2019 3:35 pm |
RNS |
Holding(s) in Company |
| 13th Nov 2019 3:17 pm |
RNS |
Holding(s) in Company |
| 11th Nov 2019 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 11th Nov 2019 2:00 pm |
RNS |
Price Monitoring Extension |
| 11th Nov 2019 7:00 am |
RNS |
Update in relation to loan facility |
| 17th Oct 2019 4:27 pm |
RNS |
Holding(s) in Company |
| 17th Oct 2019 7:00 am |
RNS |
Trading Update |
| 15th Oct 2019 3:27 pm |
RNS |
Holding(s) in Company |
| 3rd Oct 2019 7:00 am |
RNS |
DermaPure Product Line Extension Launched |
| 10th Sep 2019 7:00 am |
RNS |
Unaudited Interim Results |
| 28th Aug 2019 7:00 am |
RNS |
Appointment of CFO |
| 15th Aug 2019 7:00 am |
RNS |
Additional manufacturing capacity secured |
| 1st Aug 2019 7:00 am |
RNS |
Directorate Change |
| 8th Jul 2019 5:03 pm |
RNS |
Holding(s) in Company |
| 20th Jun 2019 2:23 pm |
EQS |
Hardman & Co Research: Tissue Regenix (TRX): Credit facilities expand cash runway to 2021 |
| 7th Jun 2019 2:55 pm |
RNS |
Issue of Equity and Total Voting Rights |
| 4th Jun 2019 7:00 am |
RNS |
Notice of AGM |
| 4th Jun 2019 7:00 am |
RNS |
Secures Credit Facilities of up to $20m |
| 4th Jun 2019 7:00 am |
RNS |
Annual Results for the year ended 31 December 2018 |
| 21st May 2019 7:00 am |
RNS |
CEO to return to full time duties |
| 10th Apr 2019 7:20 am |
EQS |
Hardman & Co Research: Tissue Regenix (TRX): Expanded GPO coverage secured |
| 4th Apr 2019 7:26 am |
RNS |
Expands US GPO coverage for DermaPure |
| 18th Feb 2019 7:00 am |
RNS |
Change of Adviser |
| 6th Feb 2019 11:05 am |
RNS |
Second Price Monitoring Extn |
| 6th Feb 2019 11:00 am |
RNS |
Price Monitoring Extension |
| 4th Feb 2019 7:00 am |
RNS |
Trading Update |
| 17th Dec 2018 11:56 am |
EQS |
Hardman & Co Research: Tissue Regenix (TRX): 2018 in review: foundations laid for osteobiologics |
| 6th Dec 2018 7:00 am |
RNS |
Interim Management Change |
| 13th Nov 2018 7:00 am |
RNS |
Pan European distribution agreement with Arthrex |
| 29th Oct 2018 7:00 am |
RNS |
Gareth Jones commences position as CFO |
| 14th Sep 2018 7:16 am |
EQS |
Hardman & Co Research: Tissue Regenix (TRX): Strategy delivering growth above expectations |
| 3rd Sep 2018 7:00 am |
RNS |
Unaudited Interim Results |
| 2nd Aug 2018 10:10 am |
EQS |
Hardman & Co Research: Tissue Regenix (TRX): 1H'18 preview: organic plus inorganic growth |
| 2nd Aug 2018 7:00 am |
RNS |
Notice of Interim Results |
| 4th Jul 2018 7:00 am |
RNS |
Appointment of CFO |
| 25th Jun 2018 7:00 am |
RNS |
HTA License granted and UK distribution Agreement |
| 21st Jun 2018 7:10 am |
RNS |
TRX BioSurgery wins GPO Supplier Horizon Award |
